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Class IIa histone deacetylases (HDACs) are found both in the cytoplasm and in the nucleus where they
repress genes involved in several major developmental programs. In response to specific signals, the repressive
activity of class IIa HDACs is neutralized through their phosphorylation on multiple N-terminal serine
residues and 14-3-3-mediated nuclear exclusion. Here, we demonstrate that class IIa HDACs are subjected to
signal-independent nuclear export that relies on their constitutive phosphorylation. We identify EMK and
C-TAK1, two members of the microtubule affinity-regulating kinase (MARK)/Par-1 family, as regulators of this
process. We further show that EMK and C-TAK1 phosphorylate class IIa HDACs on one of their multiple
14-3-3 binding sites and alter their subcellular localization and repressive function. Using HDAC7 as a
paradigm, we extend these findings by demonstrating that signal-independent phosphorylation of the most
N-terminal serine residue by the MARK/Par-1 kinases, i.e., Ser155, is a prerequisite for the phosphorylation of
the nearby 14-3-3 site, Ser181. We propose that this multisite hierarchical phosphorylation by a variety of
kinases allows for sophisticated regulation of class IIa HDACs function.
Deacetylation of histones by histone deacetylases (HDACs)
results in a compact chromatin structure that occludes the
transcriptional machinery from accessing DNA and, as such,
HDACs mostly function as transcriptional repressors (31, 40).
The 18 human HDACs identified to date are grouped into four
distinct classes, with members of class II further subdivided
into two subclasses, IIa and IIb (49). The class IIa HDACs
(HDAC4, HDAC5, HDAC7, and HDAC9) have a modular
structure, comprising a conserved catalytic region at their C
terminus and an “adapter” N-terminal domain that plays a
central role in their regulation. First, this region contains con-
served amino acid motifs that are specialized for binding an
array of transcription factors. As an example, a short motif is
implicated in interactions with members of the MEF2 family,
and repression of MEF2-targeted promoters via recruitment of
class IIa-associated HDAC activity has been extensively docu-
mented (8, 17, 22, 25, 28, 45, 50).
The adapter domain of class IIa HDACs is also subject to
various posttranslational modifications such as proteolytic
cleavage (2, 20, 33), ubiquitination (18), sumoylation (16, 36),
and, most importantly, phosphorylation. Phosphorylation has
recently emerged as the primary mechanism in the regulation
of class IIa HDACs-mediated repression (49). In response to
various stimuli, a number of serine residues in the adapter
domain of class IIa HDACs are phosphorylated and become
docking sites for 14-3-3 proteins. Association with 14-3-3 in-
duces CMR1-dependent nuclear export and cytoplasmic accu-
mulation of class IIa HDACs with concomitant derepression of
their target promoters (13, 15, 22, 46). This nuclear export
mechanism allows for signal-dependent activation of class IIa
HDACs target genes and has proven to be crucial for various
developmental programs such as muscle differentiation (24)
and activity (27), cardiac hypertrophy (5, 50), T-cell apoptosis
(8), bone development (43), and neuron survival (3, 19).
Different signaling pathways converge on the signal-respon-
sive serine residues of class IIa HDACs. It is now well estab-
lished that members of Ca2/calmodulin-dependent protein
kinases (CaMKs) promote nuclear export of class IIa HDACs
(6, 7, 15, 19, 24, 25). Recently, we along with others have
reported that specific stimuli can induce nuclear export of class
IIa HDACs through a Ca2-independent mechanism involving
protein kinase C (PKC). Protein kinase D (PKD; also known as
PKC), a downstream effector in PKC signaling, was, indeed,
shown to directly phosphorylate HDAC5 and HDAC7 on the
serine residues that control their nucleocytoplasmic trafficking (9,
34, 42). In addition, several reports suggest that other protein
kinases might also be involved in signal-dependent phosphoryla-
tion and subcellular localization of class IIa HDACs (50, 52).
More interestingly, recent observations indicate that subcellular
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localization of class IIa HDACs might also be constitutively reg-
ulated in a signal-independent manner (3, 21).
In this study, we identified the hPar-1/MARK (microtubule
affinity-regulating kinase) kinases, EMK and C-TAK1, as con-
stitutively active kinases regulating subcellular trafficking of
class IIa HDACs. Both kinases directly phosphorylate class IIa
HDACs on their N-terminal adapter domain, promoting their
nuclear export and leading to derepression of MEF2-depen-
dent transcription. Unexpectedly, we found that, among the
multiple, conserved residues previously involved in nucleocy-
toplasmic shuttling of class IIa HDACs, MARK/Par-1 kinases
specifically target a unique site. More importantly, phosphory-
lation of this site is a prerequisite for subsequent phosphory-
lation at other serine residues. These results support a model
of hierarchical class IIa HDAC phosphorylation and establish
a new role for MARK/Par-1 kinases in the control of gene
expression.
MATERIALS AND METHODS
Plasmids, antibodies, and chemicals. C-terminal green fluorescent protein
(GFP) fusion proteins of human HDACs have been described elsewhere (8, 11,
12). Glutathione transferase (GST) fusion proteins of the N terminus (amino
acids [aa] 1 to 490) and C terminus (aa 490 to 915) of HDAC7 and the N
terminus (aa 1 to 661) of HDAC4 have been previously described (9, 12).
GST-S155, GST-S181, GST-S321, and GST-S449 constructs contain, respec-
tively, amino acids 130 to 180, 156 to 216, 267 to 345, and 396 to 490 of HDAC7,
cloned into pGEX4T1 (Pharmacia) (9). GST-HDAC4 and GST-HDAC5 corre-
spond to amino acids 221 to 272 and 234 to 285 of HDAC4 and HDAC5,
respectively. Serine-to-alanine and leucine-to-alanine substitutions were intro-
duced by PCR, and mutations were verified by direct DNA sequencing according
to standard methods. GST-Cdc25C and GST-Cdc25C(S216A) fusion proteins
have been described previously (1, 35). Expression vectors for active EMK and
C-TAK1 have been described previously (32, 35). The Nur77 Luciferase con-
struct has been described elsewhere (8).
Anti-FLAG, anti-panPKC, anti-pan14-3-3, anti-c-jun, anti-HDAC7, anti-
HDAC1, anti-actin, and anti-tubulin antibodies were purchased from Santa Cruz
Biotechonology (Santa Cruz, CA). Anti-C-TAK1, anti-ribosomal S6 kinase 1
(RSK1) and anti-RSK2, and anti-mitogen- and stress-activated protein kinase 1
(MSK1) and anti-MSK2 were obtained from Upstate Biotech (Lake Placid, NY).
Monoclonal antibody against EMK has been described elsewhere (14). Poly-
clonal antibodies against phosphorylated Ser155 and phosphorylated Ser181 were
generated by 21st Century Biochemicals (Marlboro, MA). Rabbits were immu-
nized with the KLH-linked peptides HFPLRKTVpS155EPNLKLRYKP (where
pS155 is phosphorylated Ser155) and KNPLLRKEpS181APPSLRRRP, respec-
tively, and sera were collected and purified according to the company’s proce-
dures.
Staurosporine (Alexis Biochemical Corp., Lausen, Switzerland) and leptomy-
cin B (Merck Biosciences Inc, Darmstadt, Germany) were used at concentrations
of 1 M and 10 ng/ml, respectively.
Cell culture. The following cell lines were used in these experiments: Cos7,
African green monkey, simian virus 40-transformed kidney cells (ATCC CRL-
1651); HeLa, human cervical epitheloid carcinoma (ATCC CCL-2.1); HEK293,
transformed human kidney (ATCC CRL-1573); and Do11.10 T-cell hybridomas
(47). Cell lines were grown in recommended medium (Dulbecco’s modified
Eagle’s medium [DMEM] for HeLa, HEK293, and Cos7 and RPMI 1640 me-
dium for Do11.10 cells) supplemented with 10% fetal bovine serum, 2 mM
glutamine, and 50 U/ml of streptomycin-penicillin at 37°C in a humidified incu-
bator.
RNAi. Functionally validated Stealth RNA interference (RNAi) Duopacks,
each containing two nonoverlapping Stealth RNAi molecules (duplex 1 and
duplex 2) directed against C-TAK1 or EMK, and corresponding Stealth RNAi
Negative Control were purchased from Invitrogen (Carlsbad, Calif.). HeLa cells
were plated to achieve 60 to 80% confluence at the time of transfection. GFP-
HDAC7 (for immunofluorescence analysis) or FLAG-HDAC7 (for Western
blotting analysis) proteins were transfected along with either pooled small inter-
fering RNA (siRNA) duplexes 1 for EMK and C-TAK1 (50 nM of each duplex)
or control siRNA using Lipofectamine 2000 according to the manufacturer’s
instructions. Twenty-four hours after this first transfection, cells were transfected
with pooled siRNA duplexes 2 for each kinase or with control siRNA. Cells were
then left to recover in complete medium for an additional 36 to 48 h before being
processed for immunofluorescence or Western blotting analysis as described
below.
Confocal microscopy. For steady-state immunofluorescence experiments, GFP
constructs were transiently transfected by the standard calcium phosphate
method (for Cos7 and 293 HEKcells) or with Lipofectamine 2000 (HeLa cells)
according to the manufacturer’s instructions (Invitrogen, California). Localiza-
tion of the fluorescent proteins was assessed on fixed cells (for Cos7 and HeLa)
or live cells (for HEK293) by confocal microscopy (Axivert 200 with and LSM
510 laser scanning microscope; Carl Zeiss Microscopy). When indicated, the
average percentage of cells showing nuclear exclusion of the GFP-tagged protein
was assessed by examining at least three independent fields, each containing
more than 50 cells. Imaging of living Cos7 cells was performed after transfection
with FUGENE 6 (Roche Diagnostics, Basel, Switzerland) on a confocal laser
scanning microscope (LSM 510 META; Carl Zeiss, Jena, Germany) equipped
with a 488-nm argon laser. Cells were grown and transfected in MatTek glass-
bottomed dishes (MatTek, Ashland, MA). Forty-eight hours after transfection,
cells were maintained in DMEM supplemented with 30 mM HEPES, pH 7.0.
During the measurements, the medium was kept at 37°C in an atmosphere
containing 5% CO2 using an LSM 510 Incubator S (Carl Zeiss). Quantitative
analysis of the nuclear and cytoplasmic fluorescence intensity levels was per-
formed on images of the midsection of living cells. The midsection was first
determined by a Z-stack. The nuclear/cytoplasmic ratio of fluorescence intensity
was quantified using the Image J public domain Java image processing program
(http://rsb.info.nih.gov/ij/download.htm). For quantification, the fluorescence in-
tensity in the cytoplasmic or nuclear compartment was determined in a 0.5- by
0.5-m square that was centered in the nucleus or cytoplasm, respectively (two
values per cell). Results are the means of the fluorescence intensity determined
in 20 cells expressing the GFP fusion HDAC7 proteins. The relative nuclear
fluorescence intensity (FI) was calculated using the following equation: relative
FInuc  (FInuc/n)/(FIcyt/n), where FInuc is the fluorescence intensity in the nu-
cleus, FIcyt is the relative fluorescence intensity in the cytoplasm, and n is the number
of cells examined.
For fluorescence loss in photobleaching (FLIP) experiments, a time series of
images recorded live was collected as described above. The bleach rate for each
series of images was calculated and used to correct the fluorescence intensities of
the images. For qualitative FLIP analysis, cells were imaged using the 488-nm
line of an argon laser of a Zeiss LSM510 META confocal microscope operating
at 40% laser power and 5% transmission (imaging intensity). Four imaging scans
of a single cell were performed. Then, the cytoplasm was chosen as region of
interest by the LSM 510 META software and selectively bleached four times with
100% transmission (bleaching intensity), 30 s each, followed by imaging scans at
the times indicated in the figures. At least 10 data sets were analyzed for each
time point. The background corrected nuclear fluorescence at the time before
the initial photobleaching was set as 100%.
GST fusion proteins: expression, purification, and pull-downs. HDACs por-
tions and human EMK and C-TAK1 were purified as GST fusion proteins in
BL21 RIP (receptor-interacting protein) (Stratagene) according to protocols
described elsewhere (9). For in vitro kinase (IVK) assays, purified GST-hEMK
and GST-hC-TAK1 were first eluted from the beads by incubation in 25 mM
reduced glutathione and 50 mM Tris-HCl, pH 8. Recombinant, active GST-
PKD1 was produced and purified from mammalian cells as described previously
(44).
Pull-down reactions and immunoaffinity purifications from cell extracts were
performed exactly as previously described (8, 9).
SDS-PAGE and Western blotting. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blot analysis were performed accord-
ing to standard procedures (37). Western blots were developed with an ECL
detection kit (Amersham Pharmacia Biotech).
IVK assay and in-gel kinase (IGK) assay. Purified GST fusion proteins were
incubated with a dilution of recombinant active protein kinase (0.5 g/ml) in 30
l of phosphorylation mix containing 10 M ATP with 10 Ci of [-32P]ATP, 25
mM Tris, pH 7.5, and 10 mM MgCl2. After 30 min at 30°C, reactions were
terminated by adding an equal amount of 2 SDS-PAGE sample buffer and
resolved by SDS-PAGE analysis, and phosphorylated proteins were visualized by
autoradiography.
The IGK assay protocol was a slightly modified version of (38). Briefly, pull-
down reactions were resolved by standard SDS-PAGE analysis with no exoge-
nous substrate incorporation in the gel matrix. After electrophoresis, the gel was
soaked in 20% 2-propanol in 50 mM Tris-HCl, pH 8.0, and then in buffer A (50
mM Tris-HCl with 5 mM dithiothreitol) to remove SDS. Resolved proteins were
denatured by incubating the gel for 1 h in a solution of 6 M guanidine-HCl in
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buffer A and then renatured in buffer A containing 0.04% Tween 20 overnight at
4°C. The gel was preincubated in the phosphorylation buffer (see above) omitting
the [-32P]ATP. A 10 M concentration of ATP with 100 Ci of [-32P]ATP was
then added, and the phosphorylation was allowed to proceed for 1 h at 30°C.
Finally, the gel was washed in 5% (wt/vol) trichloroacetic acid plus 1% (wt/vol)
sodium pyrophosphate, dried, and analyzed by autoradiography to detect auto-
phosphorylated proteins.
Reporter assays. Transient transfections of Do11.10 cells using the DEAE-
dextran method and dual luciferase (Promega) reporter assays have been
described before (8, 9).
Metabolic labeling and phosphorylation site analysis. For in vivo phosphory-
lation site mapping, Do11.10 cells or transfected HEK293 cells were incubated
for 3 h at 37°C in phosphate-free DMEM containing 500 Ci of [32P]orthophos-
phate per ml. Cells were then washed twice in ice-cold phosphate-buffered saline
and lysed in IPLS buffer (12). Labeled proteins were purified by immunoaffinity.
In vitro phosphorylation reactions of GST-HDAC7Nter by purified GST-hC-
TAK1, GST-EMK, or GST-PKD were performed following the IGK protocol
described above.
Purified proteins were resolved by SDS-PAGE analysis and Coomassie stain-
ing. Phosphorylated proteins were in-gel digested with trypsin. The phosphory-
lated peptides were separated by high-pressure liquid chromatography (HPLC)
on a Thermo Hypercarb column (2.1 mm by 15 cm) in an acetonitrile gradient in
0.1% (vol/vol) trifluoroacetic acid (solvent A). Elution was performed with the
following gradient program: 5 to 100% solvent B (70% [vol/vol] acetonitrile in
solvent A) over 100 min at a flow rate of 200 l/min generated by a model 1100
Agilent HPLC system. Radioactive peaks were detected by Cerenkov counting,
dried under vacuum, redissolved in 5 l of 50% (vol/vol) acetonitrile–0.3%
(vol/vol) acetic acid, and analyzed by nano-electrospray ionization tandem mass
spectrometry (MS/MS) in an LCQ Deca XP Plus ion-trap mass spectrometer
(Thermo Finnigan, San Jose, CA). Spectra were taken in full MS and zoom scan
mode to determine parent ion monoisotopic masses and their charge states.
Phosphopeptides were identified in MS/MS mode as by the loss of H3PO4 (98
Da) under low-collision-induced dissociation energy, and the phosphorylated
residue was pinpointed in MS3 mode.
RESULTS
Class IIa HDACs are constitutively phosphorylated and
bound to 14-3-3 proteins. Phosphorylation-dependent nuclear
exclusion of class IIa HDACs is thought to be mediated by at
least two signal-responsive families of kinases, the CaMKs and
PKDs. However, accumulating evidence suggests that class IIa
HDACs could also be phosphorylated in the absence of exter-
nal stimulus and implies the existence of additional HDACs
kinases distinct from CaMKs or PKD (3, 15, 21).
As a step toward the identification of these new class IIa
HDACs kinases, we first investigated whether endogenous
HDAC7 could be phosphorylated under normal growing con-
ditions. In vivo, HDAC7 is predominantly expressed in double-
positive thymocytes (8). Logically, we found that among nu-
merous cell lines tested, T-cell hybridomas express high levels
of the HDAC7 protein (data not shown). Do11.10 T-cell hy-
bridoma cells were thus metabolically labeled with inorganic
32P, and endogenous HDAC7 was recovered by immunopre-
cipitation. As shown in Fig. 1A, HDAC7 appeared as a phos-
phorylated protein after SDS-PAGE analysis and autoradiog-
raphy. Interestingly, phosphorylation of endogenous HDAC7
was almost completely abolished by treatment with staurospor-
ine, a general serine/threonine kinase inhibitor (Fig. 1A).
According to the current model, phosphorylation of specific
serine residues in class IIa HDACs creates docking sites for
14-3-3 proteins. To confirm the above observations, we thus
examined the interaction between HDAC7 and 14-3-3 proteins
in Do11.10 cells. Endogenous HDAC7 (Fig. 1B, left) or ec-
topically expressed Flag-tagged HDAC7 (Fig. 1B, right) was
immunoprecipitated and analyzed for association with endog-
enous 14-3-3 proteins. Western blot analysis revealed a consti-
tutive association between endogenous 14-3-3 proteins and
endogenous or FLAG-HDAC7 (Fig. 1B). Interestingly, treat-
ment with staurosporine resulted in a drastic reduction in the
interaction between HDAC7 and 14-3-3 proteins. Similar ob-
servations were made with HDAC4 and HDAC5 in HEK293
cells (data available on request). These results thus suggest
that class IIa HDACs exists as phosphoproteins in unstimu-
lated cells and are constitutively associated with 14-3-3 pro-
teins in a phosphorylation-dependent manner.
HDAC7 constitutively shuttles from the nucleus to the cy-
toplasm. Phosphorylation of class IIa HDACs and association
with 14-3-3 proteins controls their distribution between the
nucleus and the cytoplasm. We thus examined the steady-state
subcellular localization of GFP-HDAC4 and -HDAC7 in
HeLa cells (Fig. 1C). Under normal growth conditions, the vast
majority of cells showed predominantly cytoplasmic local-
ization of both HDAC4 and HDAC7 (Fig. 1C, No Treat-
ment). In contrast, under hypophosphorylating conditions
induced by staurosporine, both HDACs accumulated in the
nucleus (Fig. 1C).
It is now well known that class IIa HDACs show differential
subcellular localization depending on the cell line examined
(11, 15, 46). This suggests that the machinery controlling nu-
clear export of class IIa HDACs is differently effective in dif-
ferent cell types. To generalize the above observations, we
examined the effect of staurosporine in Cos7 cells, where ec-
topically expressed class IIa HDACs have been shown to lo-
calize primarily in the nucleus (11, 25, 26). In the majority of
the transfected cells, GFP-HDAC7 was, for the most part,
found in the nucleus, with only a small fraction of the protein
present in the cytoplasm. However, in about 25% of the cells,
HDAC7 was predominantly detected in the cytoplasm (Fig.
2A, No treatment). Similarly to HeLa cells, treatment with
staurosporine was associated with significant nuclear retention
of HDAC7. Indeed, after 1 h of treatment, the protein was
almost exclusively localized in the nucleus, and the proportion
of cells with predominant cytoplasmic staining dropped to less
than 5% (Fig. 2A). Of note, staurosporine also increased nu-
clear retention of GFP-HDAC7 in HEK293 cells, where it
distributes equally between the nucleus and the cytoplasm in
untreated cells (data available on request). Our observations
so far clearly unraveled basal phosphorylation and 14-3-3 bind-
ing of class IIa HDACs and point toward a constitutive, phos-
phorylation-dependent nuclear efflux of these enzymes in var-
ious normally growing cell lines. To challenge this model, we
examined the intracellular mobility of HDAC7 in Cos7 cells,
which appear to be the least potent in exporting class IIa
HDACs from the nucleus to the cytoplasm. GFP-HDAC7 was
thus expressed in Cos7 cells, and its nuclear efflux was exam-
ined on live cells using the FLIP technology. For this purpose,
the cytoplasm of transfected cells was selectively and repeat-
edly bleached, and loss of fluorescence was monitored in the
nucleus. FLIP experiments revealed a substantial loss of nu-
clear fluorescence of GFP-HDAC7 in living Cos7 cells after
bleaching of the cytoplasm (Fig. 2B). This loss of nuclear
fluorescence was completely blocked by leptomycin B, an in-
hibitor of CRM1-dependent nuclear export (Fig. 2B). Quan-
tification of the data confirmed these observations and showed
a 50% decrease in nuclear fluorescence of GFP-HDAC7
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wild type (wt) 25 min after cytoplasmic bleaching (Fig. 2C,
HDAC7wt). In accordance with the steady-state localization
data (Fig. 2A), staurosporine treatment totally abolished con-
stitutive nuclear export of HDAC7 (Fig. 2B and C). A similar
effect was observed when the four 14-3-3 binding sites of
HDAC7 (Ser155, Ser181, Ser321, and Ser449 [9]) were mutated to
alanines (Fig. 2B and C, HDAC7P). These results clearly
demonstrate a constitutive efflux of HDAC7 from the nucleus
to the cytoplasm under normal growing conditions. In addition,
they are consistent with a model in which the dynamic nuclear
export of class IIa HDACs is dependent on the constitutive
phosphorylation of their conserved 14-3-3 binding sites. This
thus implies the existence of additional class IIa HDACs ki-
nases.
An 85-kDa autophosphorylating kinase associates with the
N terminus of class IIa HDACs. In an attempt to identify the
kinases responsible for the constitutive nuclear export of class
IIa HDACs, we used the N terminus of HDAC7, which con-
tains the four previously identified phosphorylatable serines
(9), in a GST pull-down assay. The material pulled down from
unstimulated 293 cell extracts was analyzed by an IGK assay to
determine the molecular weight(s) of associated cellular ki-
nase(s). Bands of variable intensity were observed in the input
lane, revealing the presence of several constitutively active
kinases in the lysate. One band, with an apparent molecular
mass of approximately 85 kDa was specifically detected in
association with GST-HDAC7Nter (Fig. 3A). Identical results
were obtained with extracts from Cos7, NIH 3T3, HeLa,
Do11.10, and DPK cells (data not shown).
We then expressed the HDAC7 sequences surrounding each
phosphorylatable serine residue as GST fusion proteins (re-
spectively, GST-S155, GST-S181, GST-S321, and GST-S449)
FIG. 1. Class IIa HDACs are constitutively phosphorylated, bound to 14-3-3 proteins, and subjected to phosphorylation-dependent nucleo-
cytoplasmic shuttling. (A) Do11.10 cells were labeled with [32P]orthophosphate and subsequently treated with staurosporine () or left untreated
(). Endogenous HDAC7 was immunoprecipitated and analyzed by SDS-PAGE followed by Western blotting (	-HDAC7) or autoradiography
(32P). (B) Do11.10 cells, transduced with FLAG-tagged HDAC7 (right) or not (left), were left untreated or treated with staurosporine for 1 h.
Endogenous (left) or ectopically expressed HDAC7 (right) was immunoprecipitated from cell lysates using the indicated antibodies. Immuno-
precipitated material was then subjected to Western blot analysis with antibodies directed against endogenous HDAC7 (	-HDAC7), the FLAG
epitope (	-FLAG), or 14-3-3 proteins (	-14-3-3). (C) HeLa cells expressing GFP-HDAC4 or GFP-HDAC7 were either left untreated (No
Treatment) or treated with staurosporine. After 1 h of treatment, the subcellular distribution of GFP-HDACs was determined using confocal
microscopy. Bar histograms represent the mean percentages of cells showing predominant cytoplasmic localization of GFP-HDACs in each
condition. Stauro, staurosporine; IP, immunoprecipitation.
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and examined their ability to recruit the 85-kDa kinase in a
pull-down assay. Surprisingly, only the fusion protein corre-
sponding to Ser155 specifically associated with the 85-kDa ki-
nase (Fig. 3B). In addition, when Ser155 was mutated into
alanine, association with the constitutively active kinase was
greatly impaired, thus indicating that the interaction specifi-
cally involves Ser155 (Fig. 3C). To generalize our findings, we
tested other class IIa HDACs for their ability to recruit the
same 85-kDa kinase activity. Pull-down assays were carried out
with GST fusion proteins corresponding to regions of HDAC4
and HDAC5 centered on Ser246 and Ser259, respectively, the
residues corresponding to Ser155 of HDAC7. IGK assays re-
vealed that an autophosphorylating kinase with a similar mo-
lecular mass of approximately 85 kDa was highly enriched in
the material associated with GST-HDAC4, GST-HDAC5, and
GST-HDAC7 but not with GST alone (Fig. 3D). These results
show that members of class IIa HDACs can associate with a
similar, if not identical, 85-kDa autophosphorylating kinase
that is constitutively active in numerous mammalian cell lines.
The 85-kDa autophosphorylating kinase activity includes
hPar-1 kinases, C-TAK1 and EMK. The apparent molecular
weight observed in IGK assays precludes the autophosphory-
lating kinase(s) from being a member of the CaMK or PKD
families. To identify this new class IIa HDACs-associated ki-
nase, we screened the human kinome for constitutively active
serine/threonine protein kinases with apparent molecular sizes
between 80 and 100 kDa (23) and showing autophosphoryla-
tion in an IGK assay. This search identified members of the
PKC, RSK, MARK/Par-1, and MSK families. We then tested
if any of these kinases could interact with Ser155 of HDAC7.
Pull-down assays were carried out with GST-S155 or GST-
A155 and GST as a control and analyzed by sequential West-
ern blotting with antibodies directed against PKC family mem-
bers, RSK1/2, the MARK/Par-1 kinase C-TAK1, and MSK1/2.
Among these, GST-S155 specifically associated with endoge-
nous C-TAK1 (Fig. 4A). More importantly, mutation of Ser155
into alanine greatly reduced the amount of bound C-TAK1.
Because these results strongly suggested that C-TAK1 could be
the 85-kDa autophosphorylating kinase described above, we
then tested the ability of C-TAK1 to associate with other class
IIa members. As expected, GST fusion proteins corresponding
to Ser246 and Ser259 of HDAC4 and HDAC5, respectively,
were also able to specifically recruit endogenous C-TAK1 in
pull-down assays (Fig. 4B).
Other MARK/Par-1 family members include the two closely
related hPar-1c and hPar-1b/EMK that phosphorylate the mi-
crotubule-associated proteins (MAPs) MAP2, MAP4, and Tau
(10). We next investigated if EMK could participate in the
85-kDa kinase activity described above. Pull-down reactions
prepared with GST-S155 and GST-A155 were then tested for
the presence of EMK. Western blot analysis revealed that
while endogenous EMK associated with GST-S155, the inter-
action was greatly impaired by mutation of Ser155 into alanine
(Fig. 4C).
C-TAK1 phosphorylates serine 155 of HDAC7 in vitro. We
next asked whether C-TAK1 could directly phosphorylate the
N terminus of HDAC7, which contains the four phosphory-
latable serines involved in nucleocytoplasmic shuttling of
HDAC7 (i.e., Ser155, Ser181, Ser321, and Ser449). For this pur-
pose, the N- or C-terminal domains of HDAC7 were expressed
as GST fusion proteins and incubated with purified recombi-
nant C-TAK1 in an IVK assay. Since C-TAK1 has been shown
to phosphorylate Cdc25C on serine 216 (32, 35), we used
GST-Cdc25C wt and GST-Cdc25C(S216A) as controls. By
comparison with GST-Cdc25C wt, the N terminus of HDAC7
was very efficiently phosphorylated by recombinant C-TAK1
(Fig. 5A). In contrast, C-TAK1 was unable to phosphorylate
the C terminus of HDAC7 or the Cdc25C(S216A) mutant
(Fig. 5A).
Hydrophobic residues at 5, 1, and  5, as well as an
arginine at the 3 position relative to the phosphorylated
serine seem to be crucial for optimal phosphorylation by C-
TAK1 (30). Except for the presence of a hydrophobic residue
at the 5 and 1 positions, the four phosphorylation sites
previously identified in the N terminus of HDAC7 match this
consensus phosphorylation motif (Fig. 5B). These observations
suggest that C-TAK1 could directly phosphorylate HDAC7
and identify Ser155, Ser181, Ser321, and Ser449 as putative target
sites for C-TAK1. To test this hypothesis, GST fusion proteins
corresponding to each serine residue (respectively, GST-S155,
GST-S181, GST-S321, and GST-S449) were evaluated as po-
tential substrate for C-TAK1 in an IVK assay. Surprisingly,
only Ser155 was efficiently phosphorylated by recombinant C-
TAK1 (Fig. 5C).
EMK and C-TAK1 display site preference among the four
serine residues of HDAC7. To confirm and extend these ob-
servations, we performed an exhaustive analysis of C-TAK1
target sites in the N terminus of HDAC7. This region of
HDAC7 was incubated with [-32P]ATP and recombinant C-
TAK1 in vitro. A control reaction was performed in parallel
with PKD, which phosphorylates Ser155, Ser181, Ser321, and
Ser449 in vitro (9). Labeled proteins were digested with trypsin,
and the resulting peptides were separated by HPLC. Radioac-
tive fractions were then analyzed by mass spectrometry to
identify the phosphorylated residue(s). Labeling with PKD led
to four major radioactive peaks (Fig. 5D), which corresponded
to the formerly identified Ser155, Ser181, Ser321, and Ser449. In
contrast, after phosphorylation with C-TAK1, the HPLC pro-
FIG. 2. Class IIa HDACs are subjected to phosphorylation-dependent nucleocytoplasmic efflux. (A) Recombinant GFP-HDAC7 was trans-
fected into Cos7 cells. Forty-eight hours posttransfection, cells were left untreated (No Treatment) or treated with staurosporine (Stauro) for 1 h
before the localization of HDAC7 was examined by confocal microscopy. (B) Cos7 cells were transfected with constructs expressing GFP fusion
proteins corresponding to HDAC7 (HDAC7wt) or a mutant of HDAC7 in which the residues Ser155, Ser181, Ser321, and Ser449 were mutated to
alanines (HDAC7P). Forty-eight hours after transfection, cells were left untreated or treated with staurosporine (Stauro) or leptomycin B (LMB)
as indicated. The cytoplasm of transfected cells was repeatedly bleached, and the loss of fluorescence in the nuclear region was assessed by confocal
microscopy. (C) Relative loss of fluorescence in the nuclear region was determined as described in Materials and Methods. FLIP data are
represented as nonlinear fit curves according to the legend at right of the graph. HDACwt LMB, HDAC7 wt with leptomycin B treatment;
HDAC7wtStauro, HDAC7 wt with staurosporine treatment.
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file exhibited a single major phosphorylation peak (Fig. 5D).
Mass spectrometry analysis showed that this peak corre-
sponded to phosphorylated Ser155. In contrast to PKD, which
targets all four serine residues implicated in the nuclear-cyto-
plasmic shuttling of HDAC7, these results demonstrate that
C-TAK1 specifically phosphorylates Ser155 (Fig. 5C and D).
Our results showed that EMK can associate with the N-
terminal Ser155 of HDAC7 (Fig. 4C). In addition, sequences
FIG. 3. The N terminus of class IIa HDACs associates with an 85-kDa autophosphorylating kinase. (A) The N terminus of HDAC7 was expressed
as a GST fusion protein (GST-Nter) and incubated with total cellular extracts from unstimulated, normally growing HEK293 cells. A control reaction
was performed in parallel with the GST protein alone. Associated autophosphorylating kinase activities were revealed by IGK assay and autoradiography.
The input lane corresponds to 10% of the lysate engaged in the pull-down. (B) GST fusion proteins corresponding to the sequences surrounding the four
phosphorylatable serine residues in HDAC7 (GST-S155, GST-S181, GST-S321, and GST-S449) were used in independent pull-down reactions with
lysates from HEK293 cells. Autophosphorylating protein kinase activities in the associated material were detected by IGK assay. The gel was stained with
Coomassie, dried, and analyzed by autoradiography. The lane marked “input” equals 10% of the cell lysate used in the reaction. (C) A GST fusion protein
corresponding to the sequences around Ser155 of HDAC7 (GST-S155) was incubated with HEK293 cell extracts in a pull-down assay. A mutant fusion
protein harboring a serine to alanine substitution (GST-A155) was used as control. Pull-down reactions were resolved by SDS-PAGE and analyzed by
IGK assay. The gel was stained with Coomassie and dried, and autophosphorylating protein kinase activity was visualized by autoradiography. Input
amounts to 10% of the cell lysate were used in each reaction. (D) GST fusion proteins corresponding to Ser246 of HDAC4, Ser259 of HDAC5, and Ser155
of HDAC7 (GST-HDAC4, GST-HDAC5, and GST-HDAC7, respectively) were incubated with extracts from HEK293 cells. A control reaction was
performed with the GST protein alone. Pull-down reactions were analyzed by IGK and autoradiography to visualize autophosphorylating kinase activities.
The input lane corresponds to 10% of the material used in each reaction. IGKA, IGK assay.
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around this serine residue, which are conserved in all class
IIa HDACs (Ser246, Ser259, Ser155, and Ser220 of HDAC4,
HDAC5, HDAC7, and HDAC9, respectively), match with the
KXGS motif phosphorylated by EMK in Tau (10). We there-
fore investigated whether EMK, similarly to C-TAK1, could
phosphorylate Ser155 of HDAC7. As expected, the entire N-
terminal domain of HDAC7, which contains all four 14-3-3
binding sites, was very efficiently phosphorylated by purified
C-TAK1 or EMK in IVK assays (Fig. 5E, GST-Nter). More
importantly, when the sole Ser155 was mutated to alanine,
phosphorylation by both kinases was totally abolished (Fig. 5E,
GST-NterS155A). Taken together, these results demonstrate
the specificity of C-TAK1 and EMK for Ser155 over the three
other serine residues previously involved in the nuclear cyto-
plasmic shuttling of HDAC7.
HDAC7 is phosphorylated on Ser155 in vivo. We next exam-
ined the phosphorylation status of Ser155 on endogenous
HDAC7 in vivo. For this purpose, we first developed an anti-
body that specifically recognizes the phosphorylated form of
HDAC7 Ser155 (data of antibody characterization available on
request). Total extracts from Do.11.10 T-cell hybridomas,
which express high levels of endogenous HDAC7, were exam-
ined by Western blotting with the phospho-specific antibody
for Ser155. As shown in Fig. 6A, strong basal phosphorylation
of HDAC7 was consistently observed at Ser155 in normally
growing cells (Fig. 6A, 	-pS155). More importantly, Ser155
phosphorylation was totally lost when cells were treated with
staurosporine.
Because sequences around Ser155 of HDAC7 are highly con-
served in other members of the class IIa, the phospho-specific
FIG. 4. MARK/Par-1 kinases, C-TAK1 and EMK, associate with the N terminus of HDAC7. (A) GST fusion proteins corresponding to Ser155
of HDAC7 (GST-S155), to the serine-to-alanine mutant (GST-A155), or to GST alone were incubated with HEK293 cell extracts in a pull-down
assay. Reactions were resolved by SDS-PAGE and analyzed for the presence of endogenous PKC family members (	-PKC), RSK1 and RSK2
(	-RSK), C-TAK1 (	-C-TAK1), and MSK1 and MSK2 (	-MSK) by Western blotting. (B) Binding of endogenous C-TAK1 to GST fusion proteins
corresponding to Ser246 of HDAC4, Ser259 of HDAC5, and Ser155 of HDAC7 (GST-HDAC4, GST-HDAC5, and GST-HDAC7, respectively) after
a pull-down assay was analyzed by Western blotting or Coomassie staining for loading control. (C) Pull-down reactions described in panel A were
analyzed by SDS-PAGE, followed by Western blotting for detection of associated endogenous EMK or by Coomassie staining for control loading.
Input equals 10% of the cell extract used in each reaction. The arrow indicates the band corresponding to EMK in the pull-down reactions. Other
bands result from cross-reactivity of the anti-EMK antiserum with bacterial proteins copurifying with the GST-fusion proteins. WB, Western
blotting.
VOL. 26, 2006 REGULATION OF CLASS IIa HDACs BY hPar-1 KINASES 7093
antibody against Ser155 also recognizes the corresponding
phosphorylated serines in HDAC4 and HDAC5 (Ser246 and
Ser259, respectively). To generalize our observations to other
members of the class IIa, FLAG-tagged versions of HDAC4,
HDAC5, and HDAC7 were transiently expressed in HEK293
cells and examined by Western blotting using the phospho-
specific antibody (Fig. 6B, 	-pS155). Confirming our observa-
tions on endogenous HDAC7, all three class IIa HDACs
showed basal phosphorylation of their respective serine resi-
due, which was significantly reduced upon treatment with stau-
rosporine.
The above findings suggest that phosphorylation of Ser155 in
HDAC7 (or Ser246 and Ser259 in HDAC4 and HDAC5, re-
spectively) might be important for constitutive nuclear export.
To test this hypothesis, we fractionated extracts from HEK293
cells transiently transfected with FLAG-tagged HDAC4 or
HDAC7 into nuclear and cytoplasmic fractions. Confirming
our immunofluorescence data (data available on request),
comparable amounts of HDAC4- or HDAC7-FLAG were
found in both fractions (Fig. 6C). However, Western blot anal-
ysis with the phospho-specific antibody revealed that HDAC7-
phosphorylated at Ser155 and HDAC4-phosphorylated at
Ser246 were highly enriched in the cytoplasm (Fig. 6C). To
confirm and extend these observations, we performed a similar
experiment in HeLa and Cos7 cells expressing FLAG-tagged
HDAC7. In accordance with the immunofluorescence data
(Fig. 1 and 2), HDAC7 localized primarily in the cytoplasm of
HeLa cells, where it is phosphorylated on Ser155 (Fig. 6D). In
FIG. 5. C-TAK1 and EMK specifically phosphorylates Ser155 of HDAC7 in vitro. (A) The C- and N-terminal domains of HDAC7 and wild-type
or S216A mutant Cdc25C were produced as GST fusion proteins [GST-HDAC7Cter, GST-HDAC7Nter, GST-Cdc25Cwt, and GST-
Cdc25C(S216A), respectively]. Equal amounts of purified recombinant proteins were used in IVK assays with recombinant active C-TAK1. IVK
reactions were analyzed by SDS-PAGE and Coomassie staining (bottom) prior to autoradiography (top). The arrow indicates the signal resulting
from autophosphorylated C-TAK1 (rC-TAK1). (B) Sequences around the four phosphorylatable serine residues in HDAC7 match with the
canonical C-TAK1 phosphorylation motif. (C) GST-fusion proteins corresponding to the sequences surrounding Ser155, Ser181, Ser321, and Ser449
of HDAC7 were used as substrates in independent IVK assays with active recombinant C-TAK1. Reactions were resolved by SDS-PAGE, and the
gel was stained with Coomassie (bottom), dried, and analyzed by autoradiography (top). (D) The N terminus of HDAC7 was expressed as a GST
fusion protein and used as a substrate for recombinant PKD or C-TAK1 in IVK assays. Labeled proteins were resolved by SDS-PAGE and digested
with trypsin. The resulting peptides were then separated by HPLC. Positions of the peptides containing each phosphorylatable serine are indicated
on the radioactivity profile (as confirmed by mass spectrometry). (E) GST fusion proteins corresponding to the N-terminal domain of HDAC7
(GST-Nter) or to the same region with a serine to alanine substitution at position Ser155 (GST-NterS155A) were phosphorylated in vitro by EMK
or C-TAK1. IVK reactions were analyzed by SDS-PAGE and Coomassie staining (bottom) prior to autoradiography (top). MW, molecular weight.
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contrast, HDAC7 was found almost exclusively in the nucleus
of Cos7 cells, and no phosphorylation of Ser155 could be de-
tected (Fig. 6D). Taken together, these results establish a
strong correlation between phosphorylation of Ser155 and cy-
toplasmic localization of HDAC7.
EMK and C-TAK1 alter nuclear export of class IIa HDACs
and regulate their repressive activity. Our results so far
strongly suggest that in the absence of extracellular stimuli,
EMK and C-TAK1 control localization of class IIa HDACs by
phosphorylating their most N-terminal 14-3-3 binding sites
(i.e., Ser246, Ser259, and Ser155 in HDAC4, HDAC5, and
HDAC7, respectively). In Cos7 cells, class IIa HDACs are
mainly found in the nucleus, probably because the mechanisms
controlling their nuclear export are poorly efficient in these
cells. To test our model, we examined the steady-state local-
ization of HDAC7 in the presence of overexpressed EMK or
C-TAK1 in Cos7 cells. As observed before, HDAC7 was
mainly found in the nucleus of Cos7 cells when expressed alone
(Fig. 7A). In contrast, coexpression of EMK and C-TAK1
induced dramatic cytoplasmic accumulation of HDAC7. How-
ever, we did not observe convincing colocalization of HDAC7
with either MARK members in the cytosol (Fig. 7A, merged).
To generalize these observations, we tested the effect of EMK
and C-TAK1 on the subcellular localization of HDAC4. By
comparison with HDAC7, HDAC4 was even more sensitive to
cytoplasmic retention by MARK kinases, with approximately
80% of cells showing predominant cytoplasmic staining (Fig.
7B). We next tested whether cytoplasmic accumulation of class
FIG. 6. HDAC7 is phosphorylated on Ser155 in vivo. (A) Total cell lysates were prepared from Do11.10 cells which were first treated with
staurosporine () for 1 h or left untreated (). Phosphorylation of endogenous HDAC7 was detected by Western blotting with the antibody
specific for phosphorylated Ser155 (	-pS155). As a loading control, the same membrane was stripped and immunoblotted with an antibody against
endogenous HDAC7 (	-HDAC7). (B) HEK293 cells were transiently transfected with expression vectors encoding FLAG-tagged versions of
wild-type HDAC4, HDAC5, and HDAC7 or the empty vector (Empty). Total cellular extracts were analyzed by SDS-PAGE and subjected to
immunoblotting using antibodies directed either against the FLAG epitope (	-FLAG) or phosphorylated Ser155 (	-pS155). (C) Nuclear (Nuc) and
cytoplasmic (Cyto) extracts were prepared from HEK293 cells transiently expressing FLAG-tagged HDAC7 or HDAC4. Both extracts were
analyzed by Western blotting with antibodies against the FLAG epitope (	-FLAG) and phosphorylated Ser155 (	-pHDACs). As a control, extracts
were also analyzed by Western blotting with antisera against the cytoplasmic protein tubulin (	-tubulin) and the nuclear protein HDAC1
(	-HDAC1). (D) Nuclear (Nuc) and cytoplasmic (Cyto) extracts were prepared from HeLa or Cos7 cells transiently expressing FLAG-tagged
HDAC7. Equal protein amounts from each extract were analyzed by Western blotting with antisera against the FLAG epitope (	-FLAG) and
phosphorylated Ser155 (	-pS155). As a control, extracts were also analyzed by Western blotting with antibody against the cytoplasmic protein
tubulin (	-tubulin) and the nuclear protein HDAC1 (	-HDAC1). Stauro, staurosporine.
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IIa HDACs induced by MARK/Par-1 kinases resulted directly
from an increase in their nuclear export. FLIP experiments
revealed a remarkable increase in the nucleocytoplasmic efflux
of HDAC7 by both EMK and C-TAK1, resulting in less than
10% of the initial fluorescence left in the nucleus after 25 min
(Fig. 7C).
In T cells, we have shown that HDAC7 associates with
MEF2D to repress the Nur77 promoter and that this inhib-
itory action is relieved by T-cell receptor signaling which
induces HDAC7 phosphorylation and cytoplasmic relocali-
zation. (8). As EMK and C-TAK1 promote nuclear export
of class IIa HDACs, both kinases would be expected to
overcome the inhibitory activity of HDAC7 over the Nur77
promoter, even in the absence of T-cell receptor signaling.
To address this question, we used the isolated Nur77 pro-
moter in reporter assays. As expected, the transcriptional
activity of the Nur77 promoter was strongly inhibited by
HDAC7 (Fig. 7D). Overexpression of EMK or C-TAK1
totally reversed the repressive effect of wild-type HDAC7.
Of note, EMK increased the transcriptional activity of
Nur77 up to twofold above levels observed in the absence of
HDAC7.
To further assess the functional consequences of phosphor-
ylation of class IIa HDACs by MARK/Par-1 kinases, we ex-
amined the ability of EMK and C-TAK1 to activate c-jun
expression, another class IIa HDAC-repressed gene (45). For
this purpose, EMK and C-TAK1 were independently ex-
pressed in Cos7 cells, and levels of endogenous c-jun were
examined by Western blotting. As expected, ectopic expression
of EMK or C-TAK1 was associated with a marked increase in
c-jun levels (Fig. 7E).
Taken together, these data demonstrate that the MARK/
FIG. 7. EMK and C-TAK1 control nuclear export of class IIa HDACs and regulate their repressive activity. (A) Cos7 cells were transfected
with expression vectors for GFP-HDAC7 and FLAG-tagged EMK or C-TAK1. The intracellular localization of HDAC7 was detected by direct
immunofluorescence (GFP) while MARKs were revealed by indirect immunofluorescence using an AlexaFluor 568-labeled anti-FLAG antibody
(FLAG). (B) Cos7 cells were transfected with expression vectors for GFP-HDAC4 or GFP-HDAC7 and constructs for EMK or C-TAK1. The
subcellular distribution of the GFP-fused HDACs proteins was examined by confocal immunofluorescence microscopy. Bar histograms represent
the mean percentages of cells showing predominant cytoplasmic staining. (C) A construct encoding GFP-HDAC7 was transfected into Cos7 cells,
either with expressing vectors for EMK, C-TAK1, or a control plasmid (Empty). The cytoplasm of GFP-positive cells was repeatedly bleached, and
FLIP measurements were performed as described in Materials and Methods. Analyses of the FLIP data from three independent experiments are
shown as fit curves. (D) Do11.10 cells were transiently transfected with a luciferase reporter plasmid driven by the Nur77 promoter and the
expression plasmids for the indicated proteins. Luciferase activities are presented relative to the basal luciferase activity of the reporter. Results
are from five independent experiments, each performed in triplicate. (E) Total cellular lysates were prepared from Cos7 cells transiently expressing
FLAG-tagged versions of EMK and C-TAK1. Cell lysates were examined by Western blotting with antisera for c-jun, FLAG, and actin.
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Par-1 kinases EMK and C-TAK1 are physiologically relevant
kinases for class IIa HDACs and strongly support a novel role
for these kinases in gene regulation.
EMK and C-TAK1 regulate phosphorylation and cytoplas-
mic localization of class IIa HDACs in the absence of extra-
cellular stimuli. We have previously shown that PKD effi-
ciently phosphorylates Ser155 of HDAC7, even when the
leucine residue at position 5 (Leu150) is replaced with an
alanine (9). Interestingly, all C-TAK1 substrates identified so
far have a leucine at position 5 of the targeted serine (Fig.
5B). While testing the importance of this leucine residue in
EMK and C-TAK1 target recognition, we found out that the
substitution of HDAC7 Leu150 to alanine totally abolished
phosphorylation of Ser155 by both kinases (data available on
request).
Based on these results, we generated an HDAC7 mutant
specifically deficient for phosphorylation by EMK/C-TAK1
where Leu150 was mutated to alanine [HDAC7(L150A)]. We
examined the in vivo phosphorylation of Ser155 in the context
of this mutant using the phospho-specific antibody. As ob-
served above (Fig. 6), HDAC7wt showed strong basal phos-
phorylation of Ser155 and robust association with 14-3-3 pro-
teins (Fig. 8A). Interestingly, the L150A mutation totally
inhibited phosphorylation of Ser155. In addition, the same mu-
tation also reduced association with 14-3-3 proteins.
Since the HDAC7(L150A) mutant is not phosphorylated on
Ser155, it should consequently be impaired in its ability to exit
the nucleus. To verify this hypothesis, we examined the sub-
cellular localization of the L150A mutant in HeLa cells, where
HDAC7 is very efficiently exported from the nucleus. Indeed,
as shown above (Fig. 1C), wild-type HDAC7 was cytoplasmic
in the majority of normally growing HeLa cells (Fig. 8B). By
FIG. 8. EMK and c-TAK1 phosphorylate Ser155 of HDAC7 in vivo. (A) FLAG-tagged versions of wild-type HDAC7 (HDAC7wt) or the
HDAC7(L150A) mutant were transiently expressed in HEK293 cells, immunoprecipitated, and examined by Western blot analysis with antibodies
directed against the FLAG epitope (	-FLAG), 14-3-3 family members (	-14-3-3), or HDAC7 phosphorylated at Ser155 (	-pS155). (B) HeLa cells
were transfected with constructs encoding GFP fusion proteins of wild-type HDAC7 (HDAC7wt) or the HDAC7(L150A) mutant. Subcellular
localization of the fluorescent proteins was observed by confocal microscopy. (C) Cos7 cells were transfected with constructs encoding GFP-tagged
wild-type or L150A HDAC7. Cytoplamsic photobleaching and FLIP measurements were performed as described in Materials and Methods.
Graphical analyses of the FLIP data from at least three independent experiments are shown as fit curves. (D) HeLa cells were transfected with
FLAG-tagged HDAC7, along with pooled siRNA against EMK and C-TAK1 or with control siRNA. The next day, cells were transfected with a
mix of siRNAs targeting an alternative sequence both in EMK and C-TAK1 or with control siRNA (see Materials and Methods). Seventy-two
hours after the initial transfection, cells were harvested and lysed. Whole-cell lysates were analyzed by Western blotting with antibodies against
EMK, C-TAK1, actin, the FLAG epitope or phosphorylated Ser155. (E) HeLa cells were transfected with an expression vector for GFP-HDAC7
along with pools of siRNAs directed against two different sequences of both EMK and C-TAK1 or control siRNA, as described in panel D. Sixty
hours after the initial transfection, localization of GFP-HDAC7 was examined by confocal immunofluorescence microscopy. Bar histograms
represent the mean percentages of cells showing predominant cytoplasmic staining.
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contrast, only 30% of HeLa cells expressing the L150A
HDAC7 mutant showed predominant cytoplasmic staining
(Fig. 8B). Interestingly, FLIP experiments revealed a clear
difference between the abilities of wild-type HDAC7 and the
L150A mutant to exit the nucleus. For wild-type HDAC7, half
of the nuclear fluorescence was lost in about 10 min after
bleaching the cytoplasm, and 35% of the initial nuclear fluo-
rescence was left after 25 min (Fig. 8C). In contrast, the loss in
nuclear fluorescence was much slower for HDAC7(L150A),
which reached a plateau of 
65% of its initial value after 25
min (Fig. 8C). These experiments show that the L150A
HDAC7 mutant is greatly impaired in its ability to exit the
nucleus, which results in an altered steady-state subcellular
localization. These results thus strongly suggest that EMK
and/or C-TAK1 specifically target Ser155 of HDAC7 to control
its nuclear export.
To establish this hypothesis more firmly, we used RNAi to
inhibit endogenous C-TAK1 and EMK activities in HeLa cells.
A combination of siRNAs directed against both C-TAK1 and
EMK reduced the endogenous levels of both kinases (Fig. 8D,
left). Coincident with this reduction, we observed a substantial
decrease in the phosphorylation of Ser155 in HDAC7 (Fig. 8D,
right). As expected, knockdown of EMK and C-TAK1 also
altered subcellular distribution of HDAC7. Indeed, when
HeLa cells were cotransfected with GFP-HDAC7 and siRNAs
against EMK and C-TAK, the proportion of cells showing
FIG. 9. The 14-3-3 binding sites in HDAC7 are hierarchically phosphorylated. (A) Cos7 cells were transfected with constructs expressing GFP
fusion proteins corresponding to wild-type HDAC7 (HDAC7wt), a mutant of HDAC7 in which the residues Ser155 was mutated to alanine alone
[HDAC7(S155A)], or together with Ser181, Ser321, and Ser449 (HDAC7P). Forty-eight hours posttransfection, the cytoplasm of fluorescent cells
was bleached, and relative loss of fluorescence in the nuclear region was measured, as described in Materials and Methods. FLIP data are
represented as nonlinear fit curves according to the legend at the right of the graph. (B) HEK293 cells expressing wild-type or S155A HDAC7 were
labeled in vivo with [32P]orthophosphate. The labeled proteins were purified by immunoaffinity, digested with trypsin, and examined by HPLC
analysis as described in Materials and Methods. (C) Expression constructs for FLAG-tagged wild-type HDAC7 (HDAC7wt) or mutant of HDAC7
in which the residues Ser155, Ser181, Ser321, or Ser449 were mutated to alanine independently [HDAC7(S155A), HDAC7(S181A), HDAC7(S321A),
and HDAC7(S449A), respectively] or together (HDAC7P) were transiently expressed in HEK293 cells. Cell extracts were examined by Western
blotting with antibodies directed against the FLAG epitope (	-FLAG) or the phosphorylated forms of Ser155 (	-pS155) or Ser181 (	-pS181).
(D) HEK293 cells were transiently transfected with expression vectors encoding FLAG-tagged versions of wild-type HDAC7 (HDAC7wt) or the
L150A mutant [HDAC7(L150A)]. Total cellular extracts were analyzed by SDS-PAGE and subjected to immunoblotting using antibodies directed
against either the FLAG epitope (	-FLAG) or HDAC7 phosphorylated at Ser155 (	-pS155) or Ser181 (	-pS181). (E) HEK293 cells expressing the
L150A HDAC7 mutant were labeled in vivo with [32P]orthophosphate. The labeled protein was purified by immunoaffinity, digested with trypsin,
and examined by HPLC analysis as described in Materials and Methods.
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a predominant cytoplasmic staining decreased significantly
(Fig. 8E).
Altogether, these data strongly suggest that MARK/Par-1
kinases EMK and C-TAK1 phosphorylate class IIa HDACs on
their most upstream 14-3-3 binding site and regulate their
constitutive nuclear export in vivo.
The 14-3-3 binding sites are hierarchically phosphorylated
in HDAC7. The biological significance behind the specific con-
stitutive phosphorylation of HDAC7 Ser155 (and correspond-
ing HDAC4 Ser246, HDAC5 Ser259, and HDAC9 Ser220) by
MARK/Par-1 kinases remained elusive. To address the role of
Ser155 phosphorylation in the signal-independent nuclear efflux
of HDAC7, we examined the dynamic nuclear export of an
HDAC7 protein where Ser155 was mutated into alanine
[HDAC7(S155A)]. Results from FLIP analysis were compared
with data obtained with wild-type HDAC7 and the HDAC7P
mutant. Surprisingly, mutation of Ser155 alone had an effect
comparable to mutating simultaneously the four serine resi-
dues and almost completely abolished constitutive nuclear ex-
port, as demonstrated by a constant postbleach relative nuclear
fluorescence in HDAC7(S155A)-expressing cells (Fig. 9A).
This observation demonstrates that Ser155 plays a dominant
role in HDAC7 constitutive phosphorylation, association with
14-3-3, and nuclear export.
To further address the importance of Ser155, we examined
the phosphorylation pattern of the HDAC7(S155A) mutant
protein in vivo. For this purpose, wild-type and S155A mutant
HDAC7 proteins were metabolically labeled with [32P] ortho-
phosphate, affinity purified, and trypsin digested for HPLC
analysis. As shown in Fig. 9B, wild-type HDAC7 was found to
be constitutively phosphorylated on five major sites, among
which the four serine residues previously implicated in subcel-
lular trafficking of HDAC7, i.e., Ser155, Ser181, Ser321, and
Ser449 were identified. Very unexpectedly, the S155A mutant
exhibited a drastically different phosphorylation pattern, as the
alanine mutation at Ser155 also resulted in a complete loss of
phosphorylation at Ser181 (Fig. 9B).
We next tested whether phosphorylation of Ser181 could be
also dependent on the two other 14-3-3 sites, Ser321 or Ser449.
HDAC7 mutants, where each of the phosphorylatable serine
residues was independently mutated to alanine [HDAC7(S155A),
HDAC(S181A), HDAC7(S321A), and HDAC7(S449A)] were
thus examined by Western blotting with antibodies specific for the
phosphorylated forms of Ser155 and Ser181 (Fig. 9C) (data of
antibody characterization available on request). As expected,
phosphorylation of Ser155 was detected for all constructs except
for HDAC7(S155A). Basal phosphorylation of Ser181 was unde-
tectable after staurosporine treatment (data not shown) or in the
HDAC7(S181A) mutant, confirming the specificity of the phos-
pho-Ser181 antibody (Fig. 9C). In accordance with the HPLC
data, phosphorylation of Ser181 was totally abolished when Ser155
was mutated into alanine (Fig. 9C). Phosphorylation of Ser181 was
uniquely dependent on Ser155 as it was unaltered by the S321A or
S449A mutations. These observations thus confirm that the pres-
ence and/or the phosphorylation of Ser155 are required for sub-
sequent phosphorylation of Ser181 in vivo.
To discriminate between both hypotheses, we examined the
phosphorylation levels of Ser181 in the HDAC7(L150A) mu-
tant, where Ser155 is present but poorly phosphorylated (Fig.
8A) both by Western blotting and HLPC analysis (Fig. 9D and
E, respectively). Interestingly, the L150A mutant also showed
a concomitant reduction of Ser181 phosphorylation (Fig. 9D
and E). These results demonstrate that basal phosphorylation
of Ser155 is required for phosphorylation of Ser181 and raised
the exciting possibility that class IIa HDACs may be regulated
through a process of hierarchical phosphorylation.
DISCUSSION
Signal-dependent cytoplasmic relocalization of class IIa
HDACs is achieved through phosphorylation of multiple
serine residues by members of the CaMK and PKD families. In
addition, some recent observations suggest that the subcellular
localization of class IIa HDACs might also be constitutively
regulated in a signal-independent manner (3, 15, 21). Our
study identifies EMK and C-TAK1, two members of the
MARK/Par-1 family, as new kinases interacting with the N-
terminal adapter domain of class IIa HDACs. We have ex-
tended this finding by showing that EMK and C-TAK1 phos-
phorylate class IIa HDACs on one of their multiple 14-3-3
binding sites and alter their subcellular localization and repres-
sive function in normally growing cells. Our study identified a
new biological function for Par-1 kinases, as we provide direct
experimental evidence that they can play a role in regulating
gene transcription. An intriguing question that remains to be
addressed is whether class IIa HDACs could play noncanonical
roles in any Par-1 functions, such as regulating cell polarity,
microtubules dynamic and stability, cell cycle progression and
intracellular signaling (39).
Par-1 kinases substrate specificity. The human MARK/
Par-1 protein kinases include hPar-1a/C-TAK1 (MARK3/p78),
hPar-1b/EMK (MARK2), hPar-1c (MARK1), and hPar-1d
(MARK4/MARKL1). EMK and hPar-1c were originally iden-
tified based on their ability to phosphorylate Tau and the
related MAP proteins MAP2 and MAP4 on their homologous
KXGS motif (10). Recently, hPar-1d was also shown to phos-
phorylate the same KXGS motif (41). Strikingly, the KTVS
motif around Ser155 of HDAC7 (conserved in other class IIa
HDACs as KTAS) is very homologous to the KXGS consensus
for hPar-1b, -c, and -d. Although it remains to be formally
tested, it is logical to speculate that, in addition to EMK and
C-TAK1, hPar-1c and hPar-1d could also phosphorylate class
IIa HDACs.
Aside from other family members, C-TAK1/Par-1a exhibits
specific substrate requirements. An extensive mutational analysis
has defined aXRXXSXXXa (where  and a are, respec-
tively, a hydrophobic and a hydrophobic aliphatic residue) as its
optimal substrate phosphorylation motif (30). From this study,
the arginine residue at the 3 position relative to the phosphor-
ylated serine, as well as hydrophobic amino acids at the 1
and 5 positions, was proven to be essential for efficient phos-
phorylation by C-TAK1. Surprisingly, none of these crucial amino
acids is found around the serine residue phosphorylated by Par-1
kinases in class IIa HDACs (Ser246, Ser259, Ser155, and Ser220 of
HDAC4, HDAC 5, HDAC7, and HDAC9, respectively) (Fig.
5B). Moreover, because they contain a hydrophobic residue at
the 5 position, motifs around other phosphorylatable serines of
HDAC7, Ser181, Ser321, and Ser449 (and corresponding residues
in other class IIa HDACs) are very homologous to the optimal
C-TAK1 consensus. Nonetheless, C-TAK1 does not phosphory-
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late (Fig. 5C and D) nor does it interact with (data not shown) any
of these serine residues in vitro.
Previously identified substrates of C-TAK1 include the Cdc25C
phosphatase (32, 35), the tyrosine phosphatase PTPH1 (51), the
mitogen-activated protein kinase scaffolding protein KSR1,
and plakophilin 2 (29, 30). Strikingly, for all known substrates
of C-TAK1, the phosphorylated residue generates a 14-3-3
binding site. The identification of class IIa HDACs as C-TAK1
substrates thus provides additional evidence that C-TAK1 may
function as a master regulator in the subcellular distribution of
several proteins with diverse cellular functions. Identification
of additional endogenous substrates for C-TAK1 should con-
firm this hypothesis.
Convergence of multiple families of protein kinases on class
IIa HDACs. The 14-3-3 binding sites of class IIa HDACs are
efficiently phosphorylated by members of multiple families of
protein kinases. In response to Ca2 signaling, CaMKI, -II,
and -IV have proven to be able to induce nuclear exclusion and
cytoplasmic accumulation of class IIa HDACs in various cell
types (49). Similarly, PKC signaling leads to the activation of
PKD1, which directly phosphorylates the multiple signal-re-
sponsive serine residues on class IIa HDACs (9, 42). We have
accumulated new evidence that PKD2 and PKD3, the two
other PKD family members, can also do so (T. Seufferlein and
F. Dequiedt, unpublished observations). Here, we show that
EMK and C-TAK1, two members of the MARK/Par-1 family,
can target one of the 14-3-3 binding sites in the N terminus of
HDAC4 and HDAC7 (and presumably other class IIa mem-
bers). It thus appears that the adapter domain of class IIa
HDACs is targeted by multiple members of multiple protein
kinase families. This has been illustrated in an elegant expres-
sion screen which was published while this article was in prep-
aration (4). Looking for modulators of HDAC5 phosphoryla-
tion, the authors identified multiple protein kinases, including
MARK2.
Experimentally, the convergence of multiple protein kinase
families on the adapter domain of class IIa HDACs makes it
difficult to fortify conclusions with convincing loss-of-function
data. Knockdown of either EMK or C-TAK1 alone had no
impact on the phosphorylation of Ser155 in HDAC7 (data not
shown). As shown in Fig. 9D, only simultaneous knockdown of
both EMK and C-TAK1 led to a reduced Ser155 phosphoryla-
tion. The existence of multiple class IIa HDACs kinases con-
firms that these enzymes are regulated by different signaling
pathways and emphasizes the importance that class IIa
HDACs may have in various genetic programs. In addition, it
also highlights the fact that the functional relevance of each
proposed HDAC kinase should be envisioned in a cellular/
signaling context-dependent manner.
Multisite and hierarchical phosphorylation of class IIa
HDACs. Multisite phosphorylation often offers a sophisticated
means to regulate protein functions. In most cases, each site
impacts differently on a specific property of the protein, such as
stability, cellular localization, catalytic activity, etc. The N ter-
minus of class IIa HDACs contains multiple phosphorylation
sites, with HDAC7 having four identified phosphorylatable
serine residues within a 300-amino-acid region. Prior to the
current study, these sites were thought to be phosphorylated
indistinguishably by the same protein kinases in response to
the same signals and equally important for class IIa HDACs
nuclear export. In this context, why class IIa HDACs would
have multiple phosphorylation sites in their N terminus re-
mained obscure. Here, we establish the uniqueness and prom-
inence of the most upstream phosphorylatable serine residue
(Ser246, Ser259, and Ser155 in HDAC4, HDAC5, and HDAC7,
respectively). First, we demonstrate that this site is uniquely
and specifically phosphorylated by hPar-1 kinases in a consti-
tutive manner. In addition, we establish the primary role of this
residue in the constitutive nuclear export of class IIa HDACs.
In exploring the functional relevance of these observations for
HDAC7, we unexpectedly discovered that basal phosphoryla-
tion of Ser155 was a prerequisite to the phosphorylation of
Ser181. For the first time, these findings demonstrate that class
IIa HDACs undergo hierarchical phosphorylation of their 14-
3-3 binding sites. Although it remains to be formally tested, it
is tempting to speculate that similar hierarchical phosphoryla-
tions exist for other sites on HDAC7 and for other members of
the class IIa family.
Par-1 kinases are constitutively active enzymes, and, accord-
ingly, we observed constitutive phosphorylation of the most
upstream phosphorylatable serine residue in class IIa HDACs.
In this context, phosphorylation of the Par-1 target site has two
important functions. First, it recruits 14-3-3 proteins and reg-
ulates the nucleocytoplasmic fluxes of the class IIa HDACs in
the absence of any extracellular signaling. Second, phosphory-
lation of this particular site in HDAC7 allows subsequent
phosphorylation of another 14-3-3 binding site, Ser181, which is
also important for nuclear efflux (data not shown). These find-
ings thus confer a central role to the most upstream phosphor-
ylatable serine residue of class IIa HDACs. The precise mech-
anism by which phosphorylation of this residue would promote
phosphorylation at other sites of class IIa HDACs remains
unknown. Incorporation of a phosphate group at this site could
alter conformation of class IIa HDACs and render other serine
residues accessible. Alternatively, phosphorylation of Ser155
could also create a docking site for other, still unknown, ki-
nases that require a priming phosphorylation in order to phos-
phorylate their substrate (e.g., glycogen synthase kinase 3).
Finally, binding of 14-3-3 proteins at this serine residue, sub-
sequently to its phosphorylation, could induce drastic confor-
mational changes and have a similar effect. Mutants of class IIa
HDACs that can still be phosphorylated at their most up-
stream serine residue, but deficient in 14-3-3 recruitment,
should allow to discriminate between these options.
In this study, we provide multiple demonstrations that Ser155
phosphorylation is crucial for HDAC7 nuclear efflux. First, we
show that phosphorylation of Ser155 coincides with cytoplasmic
localization (Fig. 6C and D). In addition, mutation of Ser155 to
alanine has an effect comparable to mutating the four serine
residues simultaneously (Fig. 9A). However, phosphorylation
of Ser155 has no impact on the phosphorylation of Ser321 or
Ser449 of HDAC7 (Fig. 9B). These observations thus suggest
that Ser155/Ser181 phosphorylation is necessary for nuclear ex-
port of HDAC7. Interestingly, HDAC7 nuclear localization
signal (NLS) spans amino acids 160 to 168, exactly between
Ser155 and Ser181. One speculative model would be that Ser155
would function as a “gatekeeper” (48) whose constitutive phos-
phorylation is necessary for binding of a 14-3-3 dimer but may
not be sufficient for nuclear export. By a still unknown mech-
anism, phosphorylation of Ser155 would favor subsequent phos-
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phorylation of Ser181 by a signal-responsive kinase or a still
unidentified constitutively active kinase, depending on the cel-
lular context. Dual phosphorylation of Ser155/Ser181 would si-
multaneously engage both monomeric subunits of a 14-3-3
dimer, which would prevent recognition of the NLS by impor-
tin 	. Whether masking of the NLS by a 14-3-3 dimer would be
sufficient for nuclear export or would necessitate signal-medi-
ated phosphorylation of Ser321 and/or Ser449 remains unclear.
Our study provides experimental evidence that the multiple
phosphorylation sites in class IIa HDACs display specific prop-
erties. In this context, combinatorial phosphorylation of these
enzymes by multiple kinases would allow for a flexible and
sophisticated control of their functions. Sequential or/and co-
ordinated actions of the various protein kinases on the N
terminus of class IIa HDACs would constitute a tightly regu-
lated mechanism to rapidly, adequately, and reversibly induce
expression of specific target genes in response to specific sig-
nals. Although the pieces are starting to fall into place, more
efforts are required to fully understand regulation of class IIa
HDACs by multisite phosphorylation.
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